Combined therapy for primary central nervous system lymphoma in immunocompetent patients
1995-01-01 Ferreri, Ajm; Reni, M; Bolognesi, A; Verusio, C; Villa, E
Resected pancreatic cancer: A proposal for a prognostic score
2005-01-01 Dell'Oro, S; Passoni, P; Balzano, G; Bonetto, E; Scaltrini, F; Zerbi, A; Staudacher, C; Villa, E; Di Carlo, V; Reni, M
Therapeutic management of refractory or relapsed primary central nervous system lymphomas
2001-01-01 Reni, M; Ferreri, Ajm
Present and future treatment options for primary CNS lymphoma
2015-01-01 Citterio, G; Reni, M; Ferreri, Ajm
Meningioma
2008-01-01 Marosi, C; Hassler, M; Roessler, K; Reni, M; Sant, M; Mazza, E; Vecht, C
Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2016-01-01 Mazza, E; Brandes, A; Zanon, S; Eoli, M; Lombardi, G; Faedi, M; Franceschi, E; Reni, M
Glioblastoma in adults
2008-01-01 Brandes, Aa; Tosoni, A; Franceschi, E; Reni, M; Gatta, G; Vecht, C
Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma
2013-01-01 Aprile, ; Avellini, ; Reni, M; Mazzer, ; Foltran, ; Rossi, ; Cereda, ; Iaiza, ; Fasola, ; Piga,
Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)
2005-01-01 Ferreri, Aj; Dell'Oro, S; Foppoli, M; Brandes, Aa; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Reni, M
Primary central nervous system lymphoma
2007-01-01 Ferreri, ANDRES JOSE MARIA; Reni, M
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back
2013-01-01 Avan, ; Pacetti, ; Reni, M; Milella, ; Vasile, ; Mambrini, ; Vaccaro, ; Caponi, ; Cereda, ; Peters, ; G., J.; Cantore, ; Giovannetti,
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma
2000-01-01 Reni, M; Ferreri, Ajm; Landoni, C; Villa, E
Temozolomide as salvage treatment in primary brain lymphomas
2007-01-01 Reni, M; Zaja, F; Mason, W; Perry, J; Mazza, E; Spina, M; Bordonaro, R; Ilariucci, F; Faedi, M; Corazzelli, G; Manno, P; Franceschi, E; Pace, A; Candela, M; Abbadessa, A; Stelitano, C; Latte, G; Ferreri, Ajm
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
2004-01-01 Ferreri, Ajm; Guerra, E; Regazzi, M; Pasini, F; Arnbrosetti, A; Pivnik, A; Gubkin, A; Calderoni, A; Spina, M; Brandes, A; Ferrarese, F; Rognone, A; Govi, S; Dell'Oro, S; Locatelli, M; Villa, E; Reni, M
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
2005-01-01 Stupp, R; Mason, Wp; van den Bent, Mj; Weller, M; Fisher, B; Taphoorn, Mjb; Belanger, K; Brandes, Aa; Marosi, C; Bogdahn, U; Curschmann, J; Janzer, Rc; Ludwin, Sk; Gorlia, T; Allgeier, A; Lacombe, D; Cairncross, Jg; Eisenhauer, E; Mirimanoff, Ro; Van Den Weyngaert, D; Kaendler, S; Krauseneck, P; Vinolas, N; Villa, S; Wurm, Re; Maillot, Mhb; Spagnolli, F; Kantor, G; Malhaire, Jp; Renard, L; De Witte, O; Scandolaro, L; Vecht, Cj; Maingon, P; Lutterbach, J; Kobierska, A; Bolla, M; Souchon, R; Mitine, C; Tzuk-Shina, T; Kuten, A; Haferkamp, G; de Greve, J; Priou, F; Menten, J; Rutten, I; Clavere, P; Malmstrom, A; Jancar, B; Newlands, E; Pigott, K; Twijnstra, A; Chinot, O; Reni, M; Boiardi, A; Fabbro, M; Campone, M; Bozzino, J; Frenay, M; Gijtenbeek, J; Brandes, Aa; Delattre, Jy; Bogdahn, U; De Paula, U; van den Bent, Mj; Hanzen, C; Pavanato, G; Schraub, S; Pfeffer, R; Soffietti, R; Weller, M; Kortmann, Rd; Taphoorn, M; Torrecilla, Jl; Marosi, C; Grisold, W; Huget, P; Forsyth, P; Fulton, D; Kirby, S; Wong, R; Fenton, D; Fisher, B; Cairncross, G; Whitlock, P; Belanger, K; Burdette-Radoux, S; Gertler, S; Saunders, S; Laing, K; Siddiqui, J; Martin, La; Gulavita, S; Perry, J; Mason, W; Thiessen, B; Pai, H; Alam, Zy; Eisenstat, D; Mingrone, W; Hofer, S; Pesce, G; Curschmann, J; Dietrich, Py; Stupp, R; Mirimanoff, Ro; Thum, P; Baumert, B; Ryan, G
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
2007-01-01 Reni, M; Cereda, S; Galli, L
Plasma homocysteine levels in 10 patients with polycythemia.
1997-01-01 Tonon, G; Boyd, K; Lecchi, A; Lombardi, R; Porcella, A; Cattaneo, M
Target delineation in post-operative radiotherapy of brain gliomas: Interobserver variability and impact of image registration of MR (pre-operative) images on treatment planning CT scans
2005-01-01 Cattaneo, Gm; Reni, M; Rizzo, G; Castellone, P; Ceresoli, Gl; Cozzarini, C; Ferreri, Ajm; Passoni, P; Calandrino, R
Somatic mutations affect key pathways in lung adenocarcinoma
2008-01-01 Ding, L; Getz, G; Wheeler, Da; Mardis, Ea; Mclellan, Md; Cibulskis, K; Sougnez, C; Greulich, H; Muzny, Dm; Morgan, Mb; Fulton, L; Fulton, Rs; Zhang, Q; Wendl, Mc; Lawrence, Ms; Larson, De; Chen, K; Dooling, Dj; Sabo, A; Hawes, Ac; Shen, H; Jhangiani, Sh; Lewis, Lr; Hall, O; Zhu, Y; Mathew, T; Ren, Y; Yao, J; Scherer, Se; Clerc, K; Metcalf, Ga; Ng, B; Milosavljevic, A; Gonzalez-Garay, Ml; Osborne, Jr; Meyer, R; Shi, X; Tang, Y; Koboldt, Dc; Lin, L; Abbott, R; Miner, Tl; Pohl, C; Fewell, G; Haipek, C; Schmidt, H; Dunford-Shore, Bh; Kraja, A; Crosby, Sd; Sawyer, Cs; Vickery, T; Sander, S; Robinson, J; Winckler, W; Baldwin, J; Chirieac, Lr; Dutt, A; Fennell, T; Hanna, M; Johnson, Be; Onofrio, Rc; Thomas, Rk; Tonon, G; Weir, Ba; Zhao, X; Ziaugra, L; Zody, Mc; Giordano, T; Orringer, Mb; Roth, Ja; Spitz, Mr; Wistuba, Ii; Ozenberger, B; Good, Pj; Chang, Ac; Beer, Dg; Watson, Ma; Ladanyi, M; Broderick, S; Yoshizawa, A; Travis, Wd; Pao, W; Province, Ma; Weinstock, Gm; Varmus, He; Gabriel, Sb; Lander, Es; Gibbs, Ra; Meyerson, M; Wilson, Rk.
Tumour-stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
2014-01-01 Heinemann, V; Reni, M; Ychou, M; Richel, Dj; Macarulla, T; Ducreux, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combined therapy for primary central nervous system lymphoma in immunocompetent patients | 1-gen-1995 | Ferreri, Ajm; Reni, M; Bolognesi, A; Verusio, C; Villa, E | |
| Resected pancreatic cancer: A proposal for a prognostic score | 1-gen-2005 | Dell'Oro, S; Passoni, P; Balzano, G; Bonetto, E; Scaltrini, F; Zerbi, A; Staudacher, C; Villa, E; Di Carlo, V; Reni, M | |
| Therapeutic management of refractory or relapsed primary central nervous system lymphomas | 1-gen-2001 | Reni, M; Ferreri, Ajm | |
| Present and future treatment options for primary CNS lymphoma | 1-gen-2015 | Citterio, G; Reni, M; Ferreri, Ajm | |
| Meningioma | 1-gen-2008 | Marosi, C; Hassler, M; Roessler, K; Reni, M; Sant, M; Mazza, E; Vecht, C | |
| Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) | 1-gen-2016 | Mazza, E; Brandes, A; Zanon, S; Eoli, M; Lombardi, G; Faedi, M; Franceschi, E; Reni, M | |
| Glioblastoma in adults | 1-gen-2008 | Brandes, Aa; Tosoni, A; Franceschi, E; Reni, M; Gatta, G; Vecht, C | |
| Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma | 1-gen-2013 | Aprile, ; Avellini, ; Reni, M; Mazzer, ; Foltran, ; Rossi, ; Cereda, ; Iaiza, ; Fasola, ; Piga, | |
| Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL) | 1-gen-2005 | Ferreri, Aj; Dell'Oro, S; Foppoli, M; Brandes, Aa; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Reni, M | |
| Primary central nervous system lymphoma | 1-gen-2007 | Ferreri, ANDRES JOSE MARIA; Reni, M | |
| Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back | 1-gen-2013 | Avan, ; Pacetti, ; Reni, M; Milella, ; Vasile, ; Mambrini, ; Vaccaro, ; Caponi, ; Cereda, ; Peters, ; G., J.; Cantore, ; Giovannetti, | |
| Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma | 1-gen-2000 | Reni, M; Ferreri, Ajm; Landoni, C; Villa, E | |
| Temozolomide as salvage treatment in primary brain lymphomas | 1-gen-2007 | Reni, M; Zaja, F; Mason, W; Perry, J; Mazza, E; Spina, M; Bordonaro, R; Ilariucci, F; Faedi, M; Corazzelli, G; Manno, P; Franceschi, E; Pace, A; Candela, M; Abbadessa, A; Stelitano, C; Latte, G; Ferreri, Ajm | |
| Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas | 1-gen-2004 | Ferreri, Ajm; Guerra, E; Regazzi, M; Pasini, F; Arnbrosetti, A; Pivnik, A; Gubkin, A; Calderoni, A; Spina, M; Brandes, A; Ferrarese, F; Rognone, A; Govi, S; Dell'Oro, S; Locatelli, M; Villa, E; Reni, M | |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | 1-gen-2005 | Stupp, R; Mason, Wp; van den Bent, Mj; Weller, M; Fisher, B; Taphoorn, Mjb; Belanger, K; Brandes, Aa; Marosi, C; Bogdahn, U; Curschmann, J; Janzer, Rc; Ludwin, Sk; Gorlia, T; Allgeier, A; Lacombe, D; Cairncross, Jg; Eisenhauer, E; Mirimanoff, Ro; Van Den Weyngaert, D; Kaendler, S; Krauseneck, P; Vinolas, N; Villa, S; Wurm, Re; Maillot, Mhb; Spagnolli, F; Kantor, G; Malhaire, Jp; Renard, L; De Witte, O; Scandolaro, L; Vecht, Cj; Maingon, P; Lutterbach, J; Kobierska, A; Bolla, M; Souchon, R; Mitine, C; Tzuk-Shina, T; Kuten, A; Haferkamp, G; de Greve, J; Priou, F; Menten, J; Rutten, I; Clavere, P; Malmstrom, A; Jancar, B; Newlands, E; Pigott, K; Twijnstra, A; Chinot, O; Reni, M; Boiardi, A; Fabbro, M; Campone, M; Bozzino, J; Frenay, M; Gijtenbeek, J; Brandes, Aa; Delattre, Jy; Bogdahn, U; De Paula, U; van den Bent, Mj; Hanzen, C; Pavanato, G; Schraub, S; Pfeffer, R; Soffietti, R; Weller, M; Kortmann, Rd; Taphoorn, M; Torrecilla, Jl; Marosi, C; Grisold, W; Huget, P; Forsyth, P; Fulton, D; Kirby, S; Wong, R; Fenton, D; Fisher, B; Cairncross, G; Whitlock, P; Belanger, K; Burdette-Radoux, S; Gertler, S; Saunders, S; Laing, K; Siddiqui, J; Martin, La; Gulavita, S; Perry, J; Mason, W; Thiessen, B; Pai, H; Alam, Zy; Eisenstat, D; Mingrone, W; Hofer, S; Pesce, G; Curschmann, J; Dietrich, Py; Stupp, R; Mirimanoff, Ro; Thum, P; Baumert, B; Ryan, G | |
| PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen | 1-gen-2007 | Reni, M; Cereda, S; Galli, L | |
| Plasma homocysteine levels in 10 patients with polycythemia. | 1-gen-1997 | Tonon, G; Boyd, K; Lecchi, A; Lombardi, R; Porcella, A; Cattaneo, M | |
| Target delineation in post-operative radiotherapy of brain gliomas: Interobserver variability and impact of image registration of MR (pre-operative) images on treatment planning CT scans | 1-gen-2005 | Cattaneo, Gm; Reni, M; Rizzo, G; Castellone, P; Ceresoli, Gl; Cozzarini, C; Ferreri, Ajm; Passoni, P; Calandrino, R | |
| Somatic mutations affect key pathways in lung adenocarcinoma | 1-gen-2008 | Ding, L; Getz, G; Wheeler, Da; Mardis, Ea; Mclellan, Md; Cibulskis, K; Sougnez, C; Greulich, H; Muzny, Dm; Morgan, Mb; Fulton, L; Fulton, Rs; Zhang, Q; Wendl, Mc; Lawrence, Ms; Larson, De; Chen, K; Dooling, Dj; Sabo, A; Hawes, Ac; Shen, H; Jhangiani, Sh; Lewis, Lr; Hall, O; Zhu, Y; Mathew, T; Ren, Y; Yao, J; Scherer, Se; Clerc, K; Metcalf, Ga; Ng, B; Milosavljevic, A; Gonzalez-Garay, Ml; Osborne, Jr; Meyer, R; Shi, X; Tang, Y; Koboldt, Dc; Lin, L; Abbott, R; Miner, Tl; Pohl, C; Fewell, G; Haipek, C; Schmidt, H; Dunford-Shore, Bh; Kraja, A; Crosby, Sd; Sawyer, Cs; Vickery, T; Sander, S; Robinson, J; Winckler, W; Baldwin, J; Chirieac, Lr; Dutt, A; Fennell, T; Hanna, M; Johnson, Be; Onofrio, Rc; Thomas, Rk; Tonon, G; Weir, Ba; Zhao, X; Ziaugra, L; Zody, Mc; Giordano, T; Orringer, Mb; Roth, Ja; Spitz, Mr; Wistuba, Ii; Ozenberger, B; Good, Pj; Chang, Ac; Beer, Dg; Watson, Ma; Ladanyi, M; Broderick, S; Yoshizawa, A; Travis, Wd; Pao, W; Province, Ma; Weinstock, Gm; Varmus, He; Gabriel, Sb; Lander, Es; Gibbs, Ra; Meyerson, M; Wilson, Rk. | |
| Tumour-stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies | 1-gen-2014 | Heinemann, V; Reni, M; Ychou, M; Richel, Dj; Macarulla, T; Ducreux, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1